[Elsevier] A phase 2 trial of rilzabrutinib in IgG4-related disease |
|
This post will be closed automatically in 2026-08-29 23:33
Reward100points
|
post
reply
points
218032
30
Pursuing sensitivity-aware probability reallocation in cross-level distillation for machine unlearning
10
AI-infused knowledge and green intellectual capital: pathways to spur accounting performance drawn from RBV-KBV model and sustainability culture
10
AI technology innovation, knowledge management and corporate environmental sustainability: Evidence from Chinese patent data
10
Effect of Swiss Ball Stabilization Training on Trunk Control, Abdominal Muscle Thickness, Balance, and Motor Skills of Children With Spastic Cerebral Palsy: A Randomized, Superiority Trial
10
Towards sustainable pharmaceutical manufacturing: The rise of supercritical fluid technology
